Teladoc Health (NYSE:TDOC) Hits New 52-Week Low on Disappointing Earnings

Teladoc Health, Inc. (NYSE:TDOC) shares reached a new 52-week low during mid-day trading on Friday following a dissappointing earnings announcement. The stock traded as low as $12.65 and last traded at $13.36, with a volume of 2157832 shares trading hands. The stock had previously closed at $13.33.

The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The firm had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter in the previous year, the business earned ($0.37) earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on TDOC shares. Truist Financial dropped their target price on Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Piper Sandler lowered their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, February 21st. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a research note on Thursday, February 29th. They set an “overweight” rating and a $22.00 price target on the stock. SVB Leerink initiated coverage on shares of Teladoc Health in a report on Monday, February 26th. They set a “market perform” rating and a $17.00 price objective on the stock. Finally, Citigroup reduced their target price on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $19.67.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares in the company, valued at $579,358.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock valued at $2,038,251 in the last ninety days. 1.63% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently modified their holdings of the business. ICA Group Wealth Management LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth $28,000. Hexagon Capital Partners LLC raised its stake in Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after buying an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $36,000. GAMMA Investing LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $41,000. Finally, Principal Securities Inc. purchased a new stake in Teladoc Health during the fourth quarter worth approximately $45,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of -9.71 and a beta of 0.94. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average of $15.01 and a 200-day moving average of $17.77.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.